Ilene L Hollin

Ilene L Hollin

  • College of Public Health

    Health Services Administration and Policy

    Assistant Professor

Office Location

1301 Cecil B. Moore Avenue Ritter Annex 537

Phone

215-204-9164

Biography

Ilene L. Hollin, PhD, is currently an assistant professor in the Department of Health Services Administration and Policy within the College of Public Health at Temple University. Dr. Hollin joined the HSAP faculty having completed a post-doctoral fellowship with the Leonard D. Schaeffer Center for Health Policy and Economics at the University of Southern California (USC) and the National Pharmaceutical Council (NPC). Dr. Hollin earned her PhD in health economics and policy from the Johns Hopkins Bloomberg School of Public Health and her MPH in effectiveness and outcomes research from the Columbia University Mailman School of Public Health.

Dr. Hollin’s research interests include patient-centered decision-making, including patient and caregiver preferences and outcomes research, the value of health technologies including pharmaceuticals and health information technology, and the impact of insurance policy on access among pediatric populations. Dr. Hollin is especially interested in research that facilitates better healthcare for complex patient populations, such as those with rare diseases and children with special healthcare needs. She is also interested in bridging the gap between health research and policy analysis and is passionate about incorporating the patient perspective in all aspects of healthcare, research and policy.

Education

  • PhD, Health Economics and Policy, Johns Hopkins University School of Public Health
  • MPH, Columbia University
  • BA, American Studies; International Studies, Brandeis University

Curriculum Vitae 

Google Scholar: Ilene Hollin's Google Scholar profile

Labs: Patient-Centered Decision Making Lab

Courses Taught

Number

Name

Level

HPM 8008

Health Economics

Graduate

Selected Publications

  • Til, J.A.v., Pearce, A., Ozdemir, S., Hollin, I.L., Peay, H.L., Wu, A.W., Ostermann, J., Deal, K., & Craig, B.M. (2024). Role Preferences in Medical Decision Making: Relevance and Implications for Health Preference Research. Patient, 17(1), pp. 3-12. New Zealand. doi: 10.1007/s40271-023-00649-4

  • Hong, J., Hollin, I.L., & Ellison, T.A. (2023). Economic Evaluation in Kidney Transplantation: A Scoping Review and Novel PESTLE Stakeholder Gaps Analysis. Transplant Proc, 55(10), pp. 2419-2428. United States. doi: 10.1016/j.transproceed.2023.10.002

  • Hollin, I.L. & Ball, J.G. (2022). Does price disclosure in pharmaceutical advertising result in price transparency? Evidence from a randomized experiment. Explor Res Clin Soc Pharm, 8, p. 100180. United States. doi: 10.1016/j.rcsop.2022.100180

  • Hollin, I.L., Paskett, J., Schuster, A.L.R., Crossnohere, N.L., & Bridges, J.F.P. (2022). Best-Worst Scaling and the Prioritization of Objects in Health: A Systematic Review. Pharmacoeconomics, 40(9), pp. 883-899. New Zealand. doi: 10.1007/s40273-022-01167-1

  • Ball, J.G. & Hollin, I.L. (2022). Attention to price disclosures in direct-to-consumer prescription drug advertising and the impact on drug perceptions. Res Social Adm Pharm, 18(8), pp. 3402-3413. United States. doi: 10.1016/j.sapharm.2021.11.003

  • Nossov, S.B., Hollin, I.L., Phillips, J., & Franklin, C.C. (2022). Proximal Femoral Focal Deficiency/Congenital Femoral Deficiency: Evaluation and Management. J Am Acad Orthop Surg, 30(13), pp. e899-e910. United States. doi: 10.5435/JAAOS-D-21-01186

  • Bass, S.B., Hollin, I.L., Kelly, P.J., Alhajji, M., D’Avanzo, P., Maurer, L., Gillespie, A., Schatell, D., & Gardiner, H. (2022). Perceptions of Live Donor Kidney Transplantation Using Segmentation Analysis and Perceptual Mapping to Understand Differences by Self-Reported Health Status in People on Dialysis. Frontiers in Communication, 6, p. 785186. doi: 10.3389/fcomm.2021.785186

  • Hollin, I.L., Bonilla, B., Bagley, A., & Tucker, C.A. (2022). Social and environmental determinants of health among children with long-term movement impairment. Front Rehabil Sci, 3, p. 831070. Switzerland. doi: 10.3389/fresc.2022.831070

  • Hollin, I.L., Janssen, E., Kelley, M.A., & Bridges, J.F.P. (2021). Do people have differing motivations for participating in a stated-preference study? Results from a latent-class analysis. BMC Med Inform Decis Mak, 21(1), p. 44. England. doi: 10.1186/s12911-021-01412-1

  • Johnson, K., Hollin, I., Palumbo, A., Spitzer, J., & Sarwer, D. (2020). An Ecologic Analysis of Comorbidities in Patients with COVID-19 in Philadelphia and New York City. CommonHealth, 1(3), pp. 85-92. doi: 10.15367/ch.v1i3.407

  • Hollin, I.L., Craig, B.M., Coast, J., Beusterien, K., Vass, C., DiSantostefano, R., & Peay, H. (2020). Reporting Formative Qualitative Research to Support the Development of Quantitative Preference Study Protocols and Corresponding Survey Instruments: Guidelines for Authors and Reviewers. Patient, 13(1), pp. 121-136. New Zealand. doi: 10.1007/s40271-019-00401-x

  • Hollin, I.L., González, J.M., Buelt, L., Ciarametaro, M., & Dubois, R.W. (2020). Do Patient Preferences Align With Value Frameworks? A Discrete-Choice Experiment of Patients With Breast Cancer. MDM Policy Pract, 5(1), p. 2381468320928012. United States. doi: 10.1177/2381468320928012

  • Hollin, I.L., Donaldson, S.H., Roman, C., Aliaj, E., Riva, D., Boyle, M., & Borowitz, D. (2019). Beyond the expected: Identifying broad research priorities of researchers and the cystic fibrosis community. J Cyst Fibros, 18(3), pp. 375-377. Netherlands. doi: 10.1016/j.jcf.2018.11.010

  • Hollin, I.L., Dimmock, A.E.f., Bridges, J.F.p., Danoff, S.K., & Bascom, R. (2019). Collecting patient preference information using a Clinical Data Research Network: demonstrating feasibility with idiopathic pulmonary fibrosis. Patient Prefer Adherence, 13, pp. 795-804. New Zealand. doi: 10.2147/PPA.S201632